CC
Casdin Capital Portfolio holdings
AUM $1.1B
1-Year Return
24.98%
This Quarter Return
+44.82%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$3.36B
AUM Growth
+$1.13B
(+50%)
Cap. Flow
+$516M
Cap. Flow
% of AUM
15.36%
Top 10 Holdings %
Top 10 Hldgs %
62.51%
Holding
56
New
11
Increased
11
Reduced
2
Closed
6
Top Buys
| 1 |
Exact Sciences
EXAS
|
+$197M |
| 2 |
NVTA
Invitae Corporation
NVTA
|
+$136M |
| 3 |
BioLife Solutions
BLFS
|
+$63.8M |
| 4 |
Beam Therapeutics
BEAM
|
+$37.6M |
| 5 |
4D Molecular Therapeutics
FDMT
|
+$32.4M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$119M |
| 2 |
AMRS
Amyris Inc.
AMRS
|
+$21.6M |
| 3 |
Illumina
ILMN
|
+$9.27M |
| 4 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
+$7.69M |
| 5 |
Legend Biotech
LEGN
|
+$4.31M |
Sector Composition
| 1 | Healthcare | 84.57% |
| 2 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVTA
1
DELISTED
Invitae Corporation
NVTA
| $514M | 15.23% |
12,298,038
+3,264,095
| +36% | +$136M |
|
|
2
BioLife Solutions
BLFS
$1.24B
| $297M | 8.79% |
7,440,107
+1,600,000
| +27% | +$63.8M |
|
3
Fate Therapeutics
FATE
$110M
| $277M | 8.22% |
3,050,000
| – | – |
|
|
4
Exact Sciences
EXAS
$10.1B
| $197M | 5.83% |
+1,485,149
| New | +$197M |
|
|
BPMC
5
DELISTED
Blueprint Medicines
BPMC
| $174M | 5.15% |
1,550,000
| – | – |
|
6
Relay Therapeutics
RLAY
$700M
| $158M | 4.69% |
3,808,894
| – | – |
|
7
Twist Bioscience
TWST
$1.55B
| $141M | 4.19% |
1,000,000
| – | – |
|
8
Pacific Biosciences
PACB
$360M
| $130M | 3.84% |
5,000,000
+500,000
| +11% | +$13M |
|
9
Denali Therapeutics
DNLI
$1.92B
| $110M | 3.25% |
1,310,000
| – | – |
|
10
Agios Pharmaceuticals
AGIO
$2.11B
| $103M | 3.05% |
2,375,000
+625,000
| +36% | +$27.1M |
|
11
Alnylam Pharmaceuticals
ALNY
$60.4B
| $101M | 3% |
780,000
+160,000
| +26% | +$20.8M |
|
12
Codexis
CDXS
$220M
| $94.5M | 2.8% |
4,330,000
+345,000
| +9% | +$7.53M |
|
13
Sarepta Therapeutics
SRPT
$1.83B
| $90.4M | 2.68% |
530,000
| – | – |
|
14
CareDx
CDNA
$746M
| $86.5M | 2.56% |
1,193,335
| – | – |
|
15
Revolution Medicines
RVMD
$8.64B
| $64.7M | 1.92% |
1,634,535
| – | – |
|
|
CNST
16
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $51.4M | 1.52% |
1,785,000
+805,000
| +82% | +$23.2M |
|
17
Generation Bio
GBIO
$37.7M
| $45.7M | 1.35% |
161,121
| – | – |
|
|
DMTK
18
DELISTED
DermTech, Inc. Common Stock
DMTK
| $44.4M | 1.32% |
1,370,000
-58,572
| -4% | -$1.9M |
|
|
BNR
19
Burning Rock Biotech
BNR
$93.8M
| $44.4M | 1.32% |
192,215
| – | – |
|
20
Adaptive Biotechnologies
ADPT
$1.99B
| $42.2M | 1.25% |
713,125
| – | – |
|
21
CRISPR Therapeutics
CRSP
$5.26B
| $40.8M | 1.21% |
266,430
| – | – |
|
|
BLUE
22
DELISTED
bluebird bio
BLUE
| $39.6M | 1.17% |
70,638
| – | – |
|
23
Adverum Biotechnologies
ADVM
$64.4M
| $39.6M | 1.17% |
365,000
+90,000
| +33% | +$9.76M |
|
|
ONC
24
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.6B
| $38.8M | 1.15% |
150,000
| – | – |
|
|
25
Beam Therapeutics
BEAM
$2.15B
| $37.6M | 1.11% |
+460,000
| New | +$37.6M |
|